[ad_1]
Among coronavirus patients whose condition is severe; The United States has approved the use of Guild Sciences corrective medications for them. The Food and Drug Administration (FDA) approved the “emergency use” of corrective drugs on Friday, according to the US media outlet NBC News. In the Oval Office, President Donald Trump, the Minister of Health and Human Services, Alex Azar, Commissioner (FDA). The decision was made in a meeting between Stephen Han and the CEO of Gilead Sciences.
The White House said Wednesday (April 29) that it had received “clear evidence” of the effectiveness of remedicavir in preventing the coronavirus. Anthony Fauchi. According to a clinical trial, the renowned scientist from the United States said that among the victims, those who took remedies recovered in less time than others. However, it has not yet been shown whether this drug has a role in reducing mortality. Within days, the drug was approved for “emergency use.”
Until now, remediation has been used in clinical trials and in patients who have no other way to avoid death. After FDA approval, the use of this drug has been created for critically ill patients. From now on, doctors will be able to “prescribe prescription drug for patients treated in hospitals,” US infectious disease specialist William Schaffner told NBC.
“We are ready to deal with Corona,” Daniel O’Day, CEO of Gilead Sciences, told local media.
At the White House Wednesday, Fawcett presented data from a study of 1,063 people around the world under the auspices of the National Institute of Allergy and Infectious Diseases. He said the data showed that remediation played a clear, important and positive role in reducing the time it takes to get rid of the coronavirus. The study found that while the death rate for recovery recipients was 7 percent, the death rate for placebo recipients was 11.6 percent. However, these results are not statistically proven. This means that scientists will not be able to tell by this difference whether it actually prevents the death of remediation.
There is currently no approved drug for the treatment of patients with coronavirus. Countries around the world are investigating effective drugs. One of these is the remedy. The drug, developed by Gilead Sciences, has been tested against Ebola in the past, but without much success. However, several animal experiments at different times have shown that the drug can be effective in preventing and treating corona virus infections like SARS and Mars. This time, several countries, including China and the United States, are conducting tests to see if the remedy is effective in treating the new coronavirus, Covid-19. However, a recently published draft report by the World Health Organization states that clinical trials in China have not shown the effectiveness of remedicivir.
[ad_2]
